Inhibrx Biosciences Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Inhibrx Biosciences Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- INBX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002007919
Board of directors
-
Douglas Forsyth · DirectorSince 2024
-
Jon Faiz Kayyem · DirectorSince 2024
-
Kimberly Manhard · DirectorSince 2024
-
Kristiina Vuori M.D. · DirectorSince 2024
-
Mark Lappe · Director · Chief Executive OfficerSince 2024
Chief executives
Mark Lappe
· Chief Executive Officer
Since May 2024
Board connections
3 of this board's directors also sit on 3 other boards.
- via Jon Faiz Kayyem
- via Kristiina Vuori M.D.
- via Kimberly Manhard
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $4,499,597
- 10 purchases by 3 insiders
- Sold, last 12 months
- $11,566,510
- 8 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2026 | Jon Faiz Kayyem Director | Open-market purchase | +5,000 | $100.00 | $500,000 |
| Sep 16, 2026 | Jon Faiz Kayyem Director | Open-market purchase | +5,000 | $100.00 | $500,000 |
| Sep 15, 2026 | Kimberly Manhard Director | Open-market sale | −500 | $105.05 | $52,525 |
| Sep 14, 2026 | Kimberly Manhard Director | Open-market sale | −500 | $110.26 | $55,130 |
| Sep 11, 2026 | Kimberly Manhard Director | Open-market sale | −500 | $111.78 | $55,888 |
| Sep 9, 2026 | Kimberly Manhard Director | Open-market sale | −500 | $115.80 | $57,898 |
| Sep 8, 2026 | Douglas Forsyth Director | Open-market purchase | +2,500 | $114.65 | $286,617 |
| Sep 8, 2026 | Mark Lappe Director, Officer (Chief Executive Officer) | Open-market purchase | +5,895 | $99.29 | $585,343 |
| Sep 8, 2026 | Jon Faiz Kayyem Director | Open-market purchase | +5,000 | $113.52 | $567,580 |
| Sep 8, 2026 | Kimberly Manhard Director | Open-market sale | −500 | $115.14 | $57,570 |
| Sep 8, 2026 | Mark Lappe Director, Officer (Chief Executive Officer) | Open-market purchase | +6,605 | $100.64 | $664,719 |
| Sep 8, 2026 | Mark Lappe Director, Officer (Chief Executive Officer) | Open-market purchase | +1,100 | $107.12 | $117,836 |
| Sep 8, 2026 | Mark Lappe Director, Officer (Chief Executive Officer) | Open-market purchase | +500 | $108.24 | $54,118 |
| Sep 8, 2026 | Mark Lappe Director, Officer (Chief Executive Officer) | Open-market purchase | +1,219 | $111.88 | $136,382 |
| Sep 8, 2026 | Mark Lappe Director, Officer (Chief Executive Officer) | Open-market purchase | +9,681 | $112.28 | $1,087,001 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.